Skip to main content

Overall Decline in Cancer Deaths Expected in Europe in 2024

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 4, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, Feb. 2, 2024 -- Overall, cancer deaths in Europe are expected to decline in 2024, but an increase in colorectal cancer (CRC) is expected in younger adults, according to a study published online Jan. 28 in Annals of Oncology.

Claudia Santucci, from the University of Milan, and colleagues predicted cancer mortality figures for 2024 for the European Union, its five most populous countries, and the United Kingdom using cancer death certification and population data from the World Health Organization and Eurostat databases (from 1970 to the most available year).

The researchers predicted 1,270,800 cancer deaths for 2024 in the European Union, corresponding to age-standardized rates of 123.2 per 100,000 men (−6.5 percent versus 2018) and 79.0 per 100,000 women (−4.3 percent). Roughly 6.2 million cancer deaths have been avoided in the European Union and 1.3 million in the United Kingdom since 1988. Unfavorable predicted rates were seen for pancreatic cancer (+1.6 percent in men and +4.0 percent in women) and lung cancer for women (+0.3 percent). Since 2018, there were CRC declines in mortality at all ages in the European Union (−4.8 percent for men and −9.5 percent for women). Adults 70 years and older had the largest predicted declines in CRC mortality. For younger adults (<50 years), CRC mortality showed unfavorable trends overall in Italy and the United Kingdom, for men in Poland and Spain, and for women in Germany.

"Predicted cancer mortality rates remain favorable in the European Union and the United Kingdom, mainly in males due to earlier smoking cessation compared to females, underlining the persisting major role of tobacco on cancer mortality in Europe," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Vaginal Cancer Incidence Increasing Globally

WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...

Nudging Both Clinicians, Patients May Increase Serious Illness Conversations

TUESDAY, July 2, 2024 -- Combining clinician- and patient-directed nudges may help to promote serious illness conversations (SICs) in cancer care, according to a study published...

Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer

TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.